Vaccination against human papillomavirus: A baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs

This publication has 22 references indexed in Scilit:

• American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
  CA: A Cancer Journal for Clinicians, 2007
• Human papilloma virus (HPV) prophylactic vaccination: Challenges for public health and implications for screening
  Vaccine, 2007
• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
  British Journal of Cancer, 2006
• Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
  The Lancet, 2006
• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
  The Lancet Oncology, 2005
• Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control
  Vaccine, 2005
• Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
  The Lancet, 2004
• Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
  JNCI Journal of the National Cancer Institute, 2004
• Human Papillomavirus: Epidemiology and Public Health
  Archives of Pathology & Laboratory Medicine, 2003
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003